Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046517> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90046517 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046517 description "scientific article published on 01 April 2019" @default.
- Q90046517 description "wetenschappelijk artikel" @default.
- Q90046517 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046517 name "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 name "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 type Item @default.
- Q90046517 label "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 label "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 prefLabel "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 prefLabel "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 P1433 Q90046517-95014D32-DA4F-409B-8950-3685158D90C7 @default.
- Q90046517 P1476 Q90046517-5ACF43C9-13A2-4909-92A7-D3C214D4DFD8 @default.
- Q90046517 P2093 Q90046517-0C220B1C-8667-4D66-9353-8299085D59B1 @default.
- Q90046517 P2093 Q90046517-1C6CF73B-3E9B-43A6-A5AF-40C2B1A01EC5 @default.
- Q90046517 P2093 Q90046517-38F86FA8-E9C4-411E-80E2-7AA9EB6DF39B @default.
- Q90046517 P2093 Q90046517-42695917-74E4-43CD-B5F8-F4A3A3C268FF @default.
- Q90046517 P2093 Q90046517-540C8193-EFE7-4BCC-BFD3-67D2D4A2001D @default.
- Q90046517 P2093 Q90046517-7E73859D-0DBD-4AD1-B01D-F63205E1FE5C @default.
- Q90046517 P2093 Q90046517-BD72A8E9-B695-4B4A-93FC-8F3B0B412B8E @default.
- Q90046517 P304 Q90046517-B2CED3E0-E94F-4E05-B937-63095BE936F7 @default.
- Q90046517 P31 Q90046517-F9EECE37-FE95-4FA8-9DD5-05FEE0A8192D @default.
- Q90046517 P356 Q90046517-A1290C2F-9E84-4F52-9134-EC1021795330 @default.
- Q90046517 P478 Q90046517-F369E5AC-2DA2-4160-97D7-191BC2F8E6CB @default.
- Q90046517 P577 Q90046517-35B46D4D-85E8-426C-AE8E-B4F4AE3B486B @default.
- Q90046517 P921 Q90046517-E78E1392-8EC2-4A96-9737-01A1E5D8C5F0 @default.
- Q90046517 P356 MDZ063.031 @default.
- Q90046517 P1433 Q326122 @default.
- Q90046517 P1476 "A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant" @default.
- Q90046517 P2093 "C Zhou" @default.
- Q90046517 P2093 "J Heng" @default.
- Q90046517 P2093 "J Qu" @default.
- Q90046517 P2093 "L Liu" @default.
- Q90046517 P2093 "N Yang" @default.
- Q90046517 P2093 "W Jiang" @default.
- Q90046517 P2093 "Y Xiong" @default.
- Q90046517 P304 "ii51" @default.
- Q90046517 P31 Q13442814 @default.
- Q90046517 P356 "10.1093/ANNONC/MDZ063.031" @default.
- Q90046517 P478 "30 Suppl 2" @default.
- Q90046517 P577 "2019-04-01T00:00:00Z" @default.
- Q90046517 P921 Q3658562 @default.